Investigation of the Potential Presence of Porphyromonas gingivalis in Esophageal Squamous Cell Carcinoma (ESCC) Paraffin Embedded Tissue Samples
Novelty in Biomedicine,
Vol. 11 No. 4 (2023),
20 November 2023
,
Page 164- 169
https://doi.org/10.22037/nbm.v11i4.42256
Abstract
Background and Aim: Esophageal cancer is the eighth most common cancer and the sixth leading cause of cancer death worldwide Evidence suggests that there is a link between bacterial infection and malignancy. There are few studies on the prevalence of Porphyromonas gingivalis in esophageal squamous cell carcinoma (ESCC), so this study aimed to investigate the possible presence of this bacterium in ESCC tissue samples.
Materials and Methods: In this study, 34 esophageal squamous cell carcinoma samples were collected to evaluate the potential presence of Porphyromonas gingivalis. After extracting the DNA, the polymerase chain reaction (PCR) technique was used to detect the presence of the bacterium molecularly.
Results: The age range of the study population was 26 to 90 years, with a mean age of 63 years. Most tissue samples come from stage I cancer (73.5%). Based on the molecular analysis, no P. gingivalis was detected in any biopsy specimens
Conclusion: P. gingivalis infection and ESCC were not correlated based on the current in this study. Likely, the use of fresh samples, more accurate diagnostic methods, geographic differences, and larger sample sizes all contribute to the differences in results between related research, which can be clarified through large-scale studies.
- Porphyromonas gingivalis
- Esophageal squamous cell carcinoma
- Polymerase chain reaction
How to Cite
References
Then EO, Michell Lopez SS, Gayam V, Sunkara T, Culliford A, Gaduputi V. Esophageal cancer: an updated surveillance epidemiology and end results database analysis. World journal of oncology. 2020;11(2):55.
Malinowski B, Węsierska A, Zalewska K, Sokołowska MM, Bursiewicz W, Socha M, et al. The role of Tannerella forsythia and Porphyromonas gingivalis in pathogenesis of esophageal cancer. Infectious agents and cancer. 2019;14(1):3.
Arnold M, Laversanne M, Brown LM, Devesa SS, Bray F. Predicting the future burden of esophageal cancer by histological subtype: international trends in incidence up to 2030. American Journal of Gastroenterology. 2017;112(8):1247-55.
Gao S-G, Yang J-Q, Ma Z-K, Yuan X, Zhao C, Wang G-C, et al. Preoperative serum immunoglobulin G and A antibody to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma. BMC cancer. 2018;18(1):17.
Park D-G, Woo BH, Lee B-J, Yoon S, Cho Y, Kim Y-D, et al. Serum Levels of Interleukin-6 and Titers of Antibodies against Porphyromonas gingivalis Could Be Potential Biomarkers for the Diagnosis of Oral Squamous Cell Carcinoma. International journal of molecular sciences. 2019;20(11):2749.
Liang H, Fan J-H, Qiao Y-L. Epidemiology, etiology, and prevention of esophageal squamous cell carcinoma in China. Cancer biology & medicine. 2017;14(1):33.
Inaba H, Sugita H, Kuboniwa M, Iwai S, Hamada M, Noda T, et al. P orphyromonas gingivalis promotes invasion of oral squamous cell carcinoma through induction of pro MMP 9 and its activation. Cellular microbiology. 2014;16(1):131-45.
Al‐Haddad S, El‐Zimaity H, Hafezi‐Bakhtiari S, Rajendra S, Streutker CJ, Vajpeyi R, et al. Infection and esophageal cancer. 2014.
Arthur JC, Gharaibeh RZ, Mühlbauer M, Perez-Chanona E, Uronis JM, McCafferty J, et al. Microbial genomic analysis reveals the essential role of inflammation in bacteria-induced colorectal cancer. Nature communications. 2014;5(1):1-11.
Yang L, Lu X, Nossa CW, Francois F, Peek RM, Pei Z. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology. 2009;137(2):588-97.
Pei Z, Bini EJ, Yang L, Zhou M, Francois F, Blaser MJ. Bacterial biota in the human distal esophagus. Proceedings of the National Academy of Sciences. 2004;101(12):4250-5.
Gao S, Li S, Ma Z, Liang S, Shan T, Zhang M, et al. Presence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancer. Infectious agents and cancer. 2016;11(1):1-9.
Peters BA, Wu J, Pei Z, Yang L, Purdue MP, Freedman ND, et al. The oral microbiome and prospective risk for esophageal cancer: A population-based nested case-control study. AACR; 2017.
Chen X, Winckler B, Lu M, Cheng H, Yuan Z, Yang Y, et al. Oral microbiota and risk for esophageal squamous cell carcinoma in a high-risk area of China. PloS one. 2015;10(12):e0143603.
Whitmore SE, Lamont RJ. Oral bacteria and cancer. PLoS Pathog. 2014;10(3):e1003933.
Gnanasekaran J, Binder Gallimidi A, Saba E, Pandi K, Eli Berchoer L, Hermano E, et al. Intracellular Porphyromonas gingivalis Promotes the Tumorigenic Behavior of Pancreatic Carcinoma Cells. Cancers. 2020;12(8):2331.
Olsen I, Yilmaz Ö. Possible role of Porphyromonas gingivalis in orodigestive cancers. Journal of oral microbiology. 2019;11(1):1563410.
Atanasova KR, Yilmaz Ö. Looking in the Porphyromonas gingivalis cabinet of curiosities: the microbium, the host and cancer association. Molecular oral microbiology. 2014;29(2):55-66.
Peters BA, Wu J, Pei Z, Yang L, Purdue MP, Freedman ND, et al. Oral microbiome composition reflects prospective risk for esophageal cancers. Cancer research. 2017;77(23):6777-87.
Gao S, Li S, Ma Z, Liang S, Shan T, Zhang M, et al. Presence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancer. Infectious agents and cancer. 2016;11(1):3.
Hajishengallis G, Lamont RJ. Breaking bad: Manipulation of the host response by P orphyromonas gingivalis. European journal of immunology. 2014;44(2):328-38.
Andrian E, Mostefaoui Y, Rouabhia M, Grenier D. Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by Porphyromonas gingivalis in an engineered human oral mucosa model. Journal of cellular physiology. 2007;211(1):56-62.
Pöttgen C, Stuschke M. Radiotherapy versus surgery within multimodality protocols for esophageal cancer–a meta-analysis ofthe randomized trials. Cancer treatment reviews. 2012;38(6):599-604.
Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. The Lancet. 2013;381(9864):400-12.
Garrett WS. Cancer and the microbiota. Science. 2015;348(6230):80-6.
Norder Grusell E, Dahlen G, Ruth M, Ny L, Quiding‐Järbrink M, Bergquist H, et al. Bacterial flora of the human oral cavity, and the upper and lower esophagus. Diseases of the Esophagus. 2013;26(1):84-90.
Michaud D, Kelsey K, Papathanasiou E, Genco C, Giovannucci E. Periodontal disease and risk of all cancers among male never smokers: an updated analysis of the Health Professionals Follow-up Study. Annals of Oncology. 2016;27(5):941-7.
Guha N, Boffetta P, Wünsch Filho V, Eluf Neto J, Shangina O, Zaridze D, et al. Oral health and risk of squamous cell carcinoma of the head and neck and esophagus: results of two multicentric case-control studies. American journal of epidemiology. 2007;166(10):1159-73.
Ahn J, Segers S, Hayes RB. Periodontal disease, Porphyromonas g ingivalis serum antibody levels and orodigestive cancer mortality. Carcinogenesis. 2012;33(5):1055-8.
Hajishengallis G, Darveau RP, Curtis MA. The keystone-pathogen hypothesis. Nature Reviews Microbiology. 2012;10(10):717-25.
Bozkurt SB, Hakki SS, Hakki EE, Durak Y, Kantarci A. Porphyromonas gingivalis lipopolysaccharide induces a pro-inflammatory human gingival fibroblast phenotype. Inflammation. 2017;40(1):144-53.
Olsen I, Progulske-Fox A. Invasion of Porphyromonas gingivalis strains into vascular cells and tissue. Journal of oral microbiology. 2015;7(1):28788.
Derynck R, Akhurst RJ, Balmain A. TGF-β signaling in tumor suppression and cancer progression. Nature genetics. 2001;29(2):117-29.
Bierie B, Chung CH, Parker JS, Stover DG, Cheng N, Chytil A, et al. Abrogation of TGF-β signaling enhances chemokine production and correlates with prognosis in human breast cancer. The Journal of clinical investigation. 2009;119(6):1571-82.
Oshimori N, Oristian D, Fuchs E. TGF-β promotes heterogeneity and drug resistance in squamous cell carcinoma. Cell. 2015;160(5):963-76.
Wang H, Zhou H, Duan X, Jotwani R, Vuddaraju H, Liang S, et al. Porphyromonas gingivalis-induced reactive oxygen species activate JAK2 and regulate production of inflammatory cytokines through c-Jun. Infection and immunity. 2014;82(10):4118-26.
Wang H, Kumar A, Lamont RJ, Scott DA. GSK3β and the control of infectious bacterial diseases. Trends in microbiology. 2014;22(4):208-17.
Morandini AC, Ramos-Junior ES, Potempa J, Nguyen K-A, Oliveira AC, Bellio M, et al. Porphyromonas gingivalis fimbriae dampen P2X7-dependent interleukin-1β secretion. Journal of innate immunity. 2014;6(6):831-45.
Moffatt CE, Lamont RJ. Porphyromonas gingivalis induction of microRNA-203 expression controls suppressor of cytokine signaling 3 in gingival epithelial cells. Infection and immunity. 2011;79(7):2632-7.
Salaspuro MP. Acetaldehyde, microbes, and cancer of the digestive tract. Critical reviews in clinical laboratory sciences. 2003;40(2):183-208.
Shao D, Vogtmann E, Liu A, Qin J, Chen W, Abnet CC, et al. Microbial characterization of esophageal squamous cell carcinoma and gastric cardia adenocarcinoma from a high‐risk region of China. Cancer. 2019;125(22):3993-4002.
Yuan X, Liu Y, Kong J, Gu B, Qi Y, Wang X, et al. Different frequencies of Porphyromonas gingivalis infection in cancers of the upper digestive tract. Cancer letters. 2017;404:1-7.
Chen M-F, Lu M-S, Hsieh C-C, Chen W-C. Association between Porphyromonas gingivalis and tumor-promoting status in esophageal squamous cell carcinoma. 2020.
Gao S-G, Yang J-Q, Ma Z-K, Yuan X, Zhao C, Wang G-C, et al. Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma. BMC cancer. 2018;18(1):1-8.
- Abstract Viewed: 42 times
- PDF Downloaded: 36 times